Wednesday, November 4, 2026
TagsTherapeutics

Tag: Therapeutics

Healthcare

Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease

Ravindra Soni - 0
Healthcare

Halia Therapeutics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Ravindra Soni - 0
Healthcare

Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of HT-6184 for Myelodysplastic Syndrome (MDS)

Ravindra Soni - 0
Healthcare

Skyhawk Therapeutics Presents at Huntington's Disease Youth Organization HDYO International Congress 2025

Ravindra Soni - 0
Healthcare

Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept

Ravindra Soni - 0
Healthcare

Bharath Advanced Therapeutics (BAT) advancing Cancer treatment in India by setting new benchmarks in affordable and transformational care

Ravindra Soni - 0
Healthcare

Bharath Advanced Therapeutics (BAT) and FABA Present Cancer NEXT 2024: Pioneering Innovation in Cancer Research

Ravindra Soni - 0
Healthcare

Curio Digital Therapeutics Applauded by Frost & Sullivan for Enhancing Women's Maternal Mental Healthcare with its MamaLift and MamaLift Plus Solutions

Ravindra Soni - 0
Healthcare

Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally...

Ravindra Soni - 0
Automobile

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AN2 Therapeutics, Inc.

Ravindra Soni - 0
1234...7Page 3 of 7

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

BusinessFortnight (businessfortnight.com) is an Indian digital news and media platform that covers business, economy, banking, insurance, real estate, automobiles, aviation, and hospitality news

Contact us: editorbusinessfortnight(@)gmail.com

© BusinessFortnight.com. All Rights Reserved.